{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:24:54Z","timestamp":1789982694021,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,5,18]],"date-time":"2003-05-18T00:00:00Z","timestamp":1053216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1038\/nm878","type":"journal-article","created":{"date-parts":[[2003,5,23]],"date-time":"2003-05-23T14:46:29Z","timestamp":1053701189000},"page":"768-773","source":"Crossref","is-referenced-by-count":238,"title":["Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy"],"prefix":"10.1038","volume":"9","author":[{"given":"Masahisa","family":"Katsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Doyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Minamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,5,18]]},"reference":[{"key":"BFnm878_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy, W.R., Alter, M. & Sung, J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671\u2013680 (1968).","journal-title":"Neurology"},{"key":"BFnm878_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112, 209\u2013232 (1989).","journal-title":"Brain"},{"key":"BFnm878_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0022-510X(93)90157-T","volume":"117","author":"G Sobue","year":"1993","unstructured":"Sobue, G. et al. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J. Neurol. Sci. 117, 74\u201378 (1993).","journal-title":"J. Neurol. Sci."},{"key":"BFnm878_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","volume":"10","author":"C Mariotti","year":"2000","unstructured":"Mariotti, C. et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul. Disord. 10, 391\u2013397 (2000).","journal-title":"Neuromuscul. Disord."},{"key":"BFnm878_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt, B.J., Greenberg, C.R., Allingham-Hawkins, D.J. & Spriggsm E.L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59, 770\u2013772 (2002).","journal-title":"Neurology"},{"key":"BFnm878_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm878_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/hmg\/5.9.1253","volume":"5","author":"F Tanaka","year":"1996","unstructured":"Tanaka, F. et al. Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum. Mol. Genet. 5, 1253\u20131257 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm878_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ana.410320517","volume":"32","author":"M Doyu","year":"1992","unstructured":"Doyu, M. et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol. 32, 707\u2013710 (1992).","journal-title":"Ann. Neurol."},{"key":"BFnm878_CR9","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1212\/WNL.42.12.2300","volume":"42","author":"S Igarashi","year":"1992","unstructured":"Igarashi, S. et al. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42, 2300\u20132302 (1992).","journal-title":"Neurology"},{"key":"BFnm878_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H.Y. & Orr, H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm878_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li, M. et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44, 249\u2013254 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnm878_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0002-9440(10)65612-X","volume":"153","author":"M Li","year":"1998","unstructured":"Li, M. et al. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am. J. Pathol. 153, 695\u2013701 (1998).","journal-title":"Am. J. Pathol."},{"key":"BFnm878_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","volume":"35","author":"CA Ross","year":"2002","unstructured":"Ross, C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819\u2013822 (2002).","journal-title":"Neuron"},{"key":"BFnm878_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1471-4914(02)02332-8","volume":"8","author":"JP Taylor","year":"2002","unstructured":"Taylor, J.P. & Fischbeck, K.H. Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention? Trends Mol. Med. 8, 195\u2013197 (2002).","journal-title":"Trends Mol. Med."},{"key":"BFnm878_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"BFnm878_CR16","first-page":"293","volume":"1","author":"C Huggins","year":"1941","unstructured":"Huggins, C. & Hodges, C.V. Studies on prostatic cancer. I. The effects of castration, of estrogen and of androgen injection on serum phosphates in metastatic carcinoma of the prostate. Cancer Res. 1, 293\u2013297 (1941).","journal-title":"Cancer Res."},{"issue":"suppl. 12","key":"BFnm878_CR17","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1002\/1097-0142(19931215)72:12+<3816::AID-CNCR2820721711>3.0.CO;2-3","volume":"72","author":"F Labrie","year":"1993","unstructured":"Labrie, F. Mechanism of action and pure antiandrogenic properties of flutamide. Cancer 72 (suppl. 12), 3816\u20133827 (1993).","journal-title":"Cancer"},{"key":"BFnm878_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J.J. & Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"BFnm878_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0090-4295(96)00117-3","volume":"48","author":"JA Kemppainen","year":"1996","unstructured":"Kemppainen, J.A. & Wilson, E.M. Agonist and antagonist activities of hydroxyflutamide and casodex relate to androgen receptor stabilization. Urology 48, 157\u2013163 (1996).","journal-title":"Urology"},{"key":"BFnm878_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/(SICI)1097-4695(199912)41:4<505::AID-NEU6>3.0.CO;2-N","volume":"41","author":"S Lu","year":"1999","unstructured":"Lu, S., Simon, N.G., Wang, Y. & Hu, S. Neural androgen receptor regulation: effects of androgen and antiandrogen. J. Neurobiol. 41, 505\u2013512 (1999).","journal-title":"J. Neurobiol."},{"key":"BFnm878_CR21","doi-asserted-by":"publisher","first-page":"28395","DOI":"10.1074\/jbc.M101755200","volume":"276","author":"A Tomura","year":"2001","unstructured":"Tomura, A. et al. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J. Biol. Chem. 276, 28395\u201328401 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm878_CR22","doi-asserted-by":"publisher","first-page":"50855","DOI":"10.1074\/jbc.M209466200","volume":"277","author":"JL Walcott","year":"2002","unstructured":"Walcott, J.L. & Merry, D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 277, 50855\u201350859 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm878_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K Takeyama","year":"2002","unstructured":"Takeyama, K. et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35, 855\u2013864 (2002).","journal-title":"Neuron"},{"key":"BFnm878_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1098\/rstb.1999.0461","volume":"354","author":"KH Fischbeck","year":"1999","unstructured":"Fischbeck, K.H., Lieberman, A., Bailey, C.K., Abel, A. & Merry, D.E. Androgen receptor mutation in Kennedy's disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354, 1075\u20131078 (1999).","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"BFnm878_CR25","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","volume":"11","author":"AP Lieberman","year":"2002","unstructured":"Lieberman, A.P., Harmison, G., Strand, A.D., Olson, J.M. & Fischbeck, K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 11, 1967\u20131976 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm878_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/(SICI)1096-8628(19991229)89:4<210::AID-AJMG5>3.0.CO;2-P","volume":"89","author":"B Gottlieb","year":"1999","unstructured":"Gottlieb, .B, Pinsky, L., Beitel, L.K. & Trifiro, M. Androgen insensitivity. Am. J. Med. Genet. 89, 210\u2013217 (1999).","journal-title":"Am. J. Med. Genet."},{"key":"BFnm878_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0303-7207(95)03608-A","volume":"112","author":"HE MacLean","year":"1995","unstructured":"MacLean, H.E., Warne, G.L. & Zajac, J.D. Defects of androgen receptor function: from sex reversal to motor neurone disease. Mol. Cell. Endocrinol. 112, 133\u2013141 (1995).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnm878_CR28","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1074\/jbc.275.12.8772","volume":"275","author":"Y Kobayashi","year":"2000","unstructured":"Kobayashi, Y. et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 275, 8772\u20138778 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm878_CR29","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","volume":"23","author":"H Adachi","year":"2003","unstructured":"Adachi, H et al. HSP70 chaperone over-expression ameliorates phenotypes of the SBMA transgenic mouse model by reducing nuclear-localized mutant AR protein. J. Neurosci. 23, 2203\u20132211 (2003).","journal-title":"J. Neurosci."},{"key":"BFnm878_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/502","volume":"19","author":"CJ Cummings","year":"1998","unstructured":"Cummings, C..J, et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19, 148\u2013154 (1998).","journal-title":"Nat. Genet."},{"key":"BFnm878_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/hmg\/10.14.1511","volume":"10","author":"CJ Cummings","year":"2001","unstructured":"Cummings, C.J. et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511\u20131518 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm878_CR32","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1073\/pnas.261400698","volume":"98","author":"A McCampbell","year":"2001","unstructured":"McCampbell, A. et al. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 98, 15179\u201315184 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm878_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan, J.S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739\u2013743 (2001).","journal-title":"Nature"},{"key":"BFnm878_CR34","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly, E. et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 100, 2041\u20132046 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm878_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/bbrc.1998.9624","volume":"252","author":"Y Kobayashi","year":"1998","unstructured":"Kobayashi, Y. et al. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem. Biophys. Res. Commun. 252, 145\u2013150 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm878_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K. & Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193\u2013199 (1991).","journal-title":"Gene"},{"key":"BFnm878_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/hmg\/10.10.1039","volume":"10","author":"H Adachi","year":"2001","unstructured":"Adachi, H. et al. Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum. Mol. Genet. 10, 1039\u20131048 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm878_CR38","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0090-4295(97)00393-2","volume":"50","author":"S Luo","year":"1997","unstructured":"Luo, S. et al. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. Urology 50, 913\u2013919 (1997).","journal-title":"Urology"},{"key":"BFnm878_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier, Y. et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403\u2013406 (1995).","journal-title":"Nature"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm878","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm878.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:34:29Z","timestamp":1684449269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,18]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["BFnm878"],"URL":"https:\/\/doi.org\/10.1038\/nm878","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,18]]}}}